Sort
130,381 grants matching “hiv”
North American AIDS Cohorts Collaboration on Research and Design (NAACCORD) Renewal
$906,511Richard Douglas Moore · Johns Hopkins University · U01 · FY2020 · AI
Global Health Emerging Scholars Program
$906,500Albert Icksang Ko · Yale University · D43 · FY2023 · TW
International Center for Excellence in Research (ICER) in Uganda: Impact of ARVs
$906,484Thomas Quinn · National Institute Of Allergy And Infectious Diseases · ZIA · FY2010 · AI
Monoclonal antibody-based intervention against SIV in nonhuman primates
$906,369Mario Roederer · National Institute Of Allergy And Infectious Diseases · ZIA · FY2016 · AI
Targeting PD-1 Pathway for Functional Cure of AIDS
$906,321Rama Rao Amara · Emory University · R37 · FY2014 · AI
Host Genomic Factors in Infectious Disease Susceptibility
$906,178Daniel Cesar Douek · National Institute Of Allergy And Infectious Diseases · ZIA · FY2022 · AI
Effectiveness of Peer Navigation to Link Released HIV+ Jail Inmates to HIV Care
$906,178William E Cunningham · University Of California Los Angeles · R01 · FY2012 · DA
PROTON MRS STUDIES OF CEREBRAL INJURY IN HIV INFECTION
$906,166Tufts Medical Center · R01 · FY2000 · NS
HIV RNase H natural product inhibitors
$906,157Michael A Parniak · University Of Pittsburgh At Pittsburgh · U19 · FY2009 · AI
Nonhuman Primate Core
$906,156Hans-Peter Kiem · University Of California Los Angeles · U19 · FY2022 · AI
REPRIEVE - DCC
$906,151Udo Hoffmann · Massachusetts General Hospital · U01 · FY2017 · HL
Einstein-Mount Sinai Diabetes Research Center
$906,142Jeffrey E Pessin · Albert Einstein College Of Medicine · P30 · FY2018 · DK
Agricultural intervention for food security and HIV healthoutcomes in Kenya
$906,119Craig R Cohen · University Of California, San Francisco · R01 · FY2017 · MH
Administrative Core
$906,095Rajesh T Gandhi · Harvard University · P30 · FY2021 · AI
HIV/STI Prevention for Drug-Involved Couples
$906,060Columbia Univ New York Morningside · R01 · FY2005 · DA
Timely monitoring and response to HIV transmission networks for intensified prevention
$906,049Ann Dennis · Univ Of North Carolina Chapel Hill · R01 · FY2020 · AI
TO FACILITATE THE DEVELOPMENT AND IMPLEMENTATION OF ENHANCED COMPREHENSIVE HIV PR
$906,024Jane Baker · Philadelphia City Dept Of Public Health · U65 · FY2010 · PS
Enhanced latency reversal and reservoir clearance in macaques
$906,012Ann M Chahroudi · Emory University · R37 · FY2022 · AI
Evaluating the safety, immunogenicity and efficacy of a robust attenuated Mtb vaccine in the setting of HIV co-infection
$905,998Deepak Kaushal · Texas Biomedical Research Institute · R01 · FY2025 · AI
Comprehensive HIV Prevention Package for MSM in Southern Africa
$905,932Patrick Sean Sullivan · Emory University · R01 · FY2013 · AI
HIV-2 latency and its reversal
$905,874Athe M. Tsibris · Brigham And Women'S Hospital · R01 · FY2022 · AI
Modulating Indoleamines to Optimize Immunity in the Setting of Mtb/HIV Co-infection
$905,874Smriti Mehra · Texas Biomedical Research Institute · R01 · FY2025 · AI
Modulating Stochastic Gene Expression for Cell-fate Control and Therapeutics
$905,866Leor S Weinberger · Autonomous Therapeutics, Inc. · R37 · FY2024 · AI
Role of Memory T Cell Dynamics in SIV Infection
$905,851Louis J. Picker · Oregon Health & Science University · R37 · FY2013 · AI
Immunopathogenic Mechanisms of Human Immunodeficiency Virus (HIV) Disease
$905,798Irini Sereti · National Institute Of Allergy And Infectious Diseases · ZIA · FY2012 · AI